Ophthalmic devices panel
This article was originally published in The Gray Sheet
Executive SummaryConvening via telephone conference call on May 20; a speaker telephone will be provided at FDA facilities on 5600 Fishers Lane in Rockville, Maryland "to allow public participation in the meeting." The panel will discuss "general issues relating to" a premarket approval application for a silicone intraocular lens, as well as IOL labeling issues and a multifocal IOL guidance document. The panel also is slated to hear and comment on a presentation on the Reanalysis of the Information on the Safety and Effectiveness (RAISE) program for extended wear contact lenses. For further information contact FDA's Daniel Brown at 301/427-1080.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.